Por Renan Filho · 2026-10-10**Lead**
A sexually transmitted infection long associated with medieval plagues and gruesome lesions is making a disturbing comeback across the United States. Syphilis, which can cause open sores, rashes, and — if left untreated — irreversible damage to the brain and heart, is now spreading faster than at any point in recent decades. At the same time, standard antibiotic regimens are showing signs of failure, raising fears that the country may be entering a new era of untreatable STIs.
**Contexto**
Syphilis was once considered a disease of the past, nearly eliminated in the U.S. by the early 2000s. But over the past decade, case counts have climbed steadily, with the Centers for Disease Control and Prevention (CDC) documenting a sharp increase across all regions. The infection is caused by the bacterium *Treponema pallidum* and is transmitted through direct contact with a syphilis sore during vaginal, anal, or oral sex. Early symptoms include painless sores, but the infection can progress to a secondary stage characterized by fever, swollen lymph nodes, and a distinctive rash that can cover the entire body. In its late stages, syphilis can attack the nervous system, leading to paralysis, blindness, and dementia.
Public health experts point to several drivers behind the resurgence. Condom use has declined among certain populations, and dating apps have facilitated more anonymous sexual encounters, making contact tracing difficult. Additionally, funding for STI clinics has been cut in many states, limiting access to testing and treatment. The CDC has reported that congenital syphilis — passed from mother to baby during pregnancy — has also skyrocketed, resulting in stillbirths and severe birth defects.
But perhaps the most alarming trend is the growing evidence that standard treatments are losing their punch. For decades, a single shot of penicillin G benzathine has been the gold standard for early syphilis. However, recent case reports from several U.S. cities have documented patients who failed to respond to the standard regimen, requiring higher doses or alternative antibiotics. While full-blown resistance to penicillin remains rare, the emergence of strains with reduced susceptibility is a worrying sign. The World Health Organization has listed syphilis as one of the infections for which new treatments are urgently needed.
**Analise**
The failure of standard medicines for syphilis is not just a medical problem — it is a cultural one. The stigma surrounding STIs has historically discouraged people from seeking testing and treatment, allowing infections to fester and spread. In an era of rising antibiotic resistance, that stigma becomes even more dangerous. When patients delay care because of shame, the infection has more time to progress and to be transmitted to others. Moreover, the gruesome nature of late-stage syphilis — which can cause gummas (soft, tumor-like growths) and destruction of bone and cartilage — adds a layer of horror that fuels public fear rather than rational response.
Health officials are now calling for a multipronged approach. This includes expanding access to rapid testing, promoting the use of condoms, and investing in research for new antibiotics and vaccines. The National Institutes of Health has launched studies to evaluate higher doses of penicillin and combination therapies. But without a cultural shift that normalizes STI testing and treatment, these medical interventions may fall short. The rise of syphilis is a reminder that infectious diseases are not just biological events — they are shaped by human behavior, social norms, and public policy.
**Fontes**
- Centers for Disease Control and Prevention (CDC) — Sexually Transmitted Disease Surveillance Reports - World Health Organization (WHO) — Global Health Observatory data on syphilis - National Institutes of Health (NIH) — Research on antibiotic resistance in *Treponema pallidum* - American Sexual Health Association (ASHA) — STI stigma and testing barriers